The origin and nature of the differences between the sexes is likely to have been a subject of debate since prehistory. Many theories proposed by the ancient philosophers were interesting, if inaccurate (the "heat" of lovemaking does not determine maleness, as proposed by Aristotle, but the temperature of embryonic development is indeed important for some species). The debate began to find a good scientific basis with the beginning of the chromosome theory early this century. With the advent of modern genetics and molecular biology, for many the surprise has been that, unlike many basic developmental events, the mechanisms employed for sex determination are extremely varied. Nearly every type of regulatory mechanism known is used in the control of sex determination. Owing to this variety, the study of sex determination has provided an extremely rich source of information on how regulatory switches function in the development of nonsexual as well as sexual characters. The first Keystone Symposia on The Molecular Basis for Differences between the Sexes took place on February 12-18, 1995, at Tamarron, Colorado. The topics focused on sex determination and differentiation in humans, mice, fruit flies, and worms, although an interesting session was devoted to sex determination in other organisms. Below we review this meeting.
Primary Determinants
of Sex In Drosophila melanogaster, Caenorhabditis elegans, and mammals, sex is determined chromosomally.
For organisms such as these with XY chromosomal systems, the primary sex determinant is related either to the number of X chromosomes or the presence of the Y chromosome. Both of these types of mechanisms are used. Drosophila In Drosophila, the primary determinant of sex is the X chromosome:autosome ratio (X:A ratio). This ratio is assessed by a counting process involving the expression of X-linked numerator and autosomal denominator elements that make up the X:A ratio signal (reviewed by Cline, 1993) . The target of the X:A signal is the Sex-lethal gene (Sxl), which functions as a master switch gene that regulates both somatic sexual differentiation and X chromosome dosage compensation (and also functions in germline sex determination: see below). Early in development, an X:A Meeting Review ratio of 1 in females is counted and is responsible for activating an embryo-specific Sxl promoter. In males, the X:A ratio of 0.5 is too low for activation, and Sxl remains "off." Slightly later in development, Sxl is transcribed in both sexes by use of a different promoter, but only makes a functional product in females owing to autoregulation of its own expression by alternative RNA splicing. Using genetic screens based on interactions with the Sxl gene, a small number of genes have been identified that function as numerator (sisterless a [sis a], sis b, and runt) or denominator (deadpan [dpn]) counting elements. In addition, several maternally provided factors function either positively (such as daughterless [da] and hermaphrodite [her] ) or negatively (exrramachrochaefae [emc] and grouch0 [gro] ; Paroush et al., 1994) in the counting process (see Figure  1 ). All of these factors have homology to various classes of transcriptional regulatory factors, consistent with the fact that regulation of Sxl by the X:A signal is transcriptional. At the Keystone meeting T. Cline (University of California, Berkeley) presented the resultsof further screening for numerator and denominator elements. No new numerator elements have been identified except for the X-linked gene sis c, which has a rather weak contribution to numerator counting. Essentially, no new autosomal elements were identified, although 10 new alleles of dpn, which is a rather weak denominator element, and a cluster of very weak elements on the left arm of the second chromosome were picked up by the screen. These results taken together suggest that either the autosomal contribution to the X:A signal may be a consequence of a lot of scattered genes that individually have very minor effects or that it plays a relatively minor role in X:A counting and that perhaps the denominator includes other factors such as size of the nucleus, the mass of DNA, or both. C. elegans In C. elegans the primary determinant of sex is also the X:A ratio. Assessment of this signal leads to the development of XX hermaphrodites (which produce both sperm and eggs) and X0 males (reviewed by Parkhurst and Meneely, 1994) . The molecular nature of the X:A signal in C. elegans is currently unknown. However, evidence that discrete X:A counting elements exist came from presentations from B. Meyer and colleagues (University of California, Berkeley). A region at the left end of the X chromosome appears to contain counting elements, as two copies cause X0 lethality and one copy causes XX hermaphrodites to be sick (Akerib and Meyer, 1994) ; both phenotypes are apparently due to upsets in dosage compensation. The dose-sensitive effects of this region are likely to be due to counting elements because they act upstream of the X0 lethal gene x01-7, the earliest acting gene of the sex determination hierarchy (Figure 1 ). The region has been subdivided into three smaller dose sensitive regions, although to have an effect in XX animals, a copy of each of the three regions must be lacking. Significantly, C. Akerib reported the isolation of point mutations in one of these regions (found by suppressing the X0 lethality caused by the X duplications), indicating that counting involves specific loci. A second approach being used to identify counting elements or other factors that function upstream of x01-l is based on a xol-1::lacZ reporter construct, which gives sex-specific /acZ expression in embryos (presented by J. Kopczynski). Because high levels of x01-7 expression result in male development and low levels in female development, mutations that result in the production of increased numbers of xo/-l::/acZ-expressing embryos are being screened for. Using this approach, an X-linked mutation has been isolated (in a region of the X different from the duplications discussed above) that may also function as a signal element because it suppresses the X0 lethality caused by the X duplications but does not suppress x01-7 mutations. Taken together these results provide strong evidence that the counting process in C. elegans requires multiple discrete signal elements. Mammals In mammals, the Y chromosome establishes maleness. The primary event occurs relatively late during embryo development and is active only in the cells that will give rise to the gonads. In mice, the gonads first develop as thickenings of the primitive kidney or mesonephros, at about 10 days postcoitum (dpc) and are identical in females and males (this stage is called "indifferent") until 2 days later, when morphological differences between the sexes can first be observed. The basic gonadal developmental pathway in mammals is female, but this is overridden in the male owing to the action of Sry, the gene in the sex-determining region of the Y chromosome. Srytriggers testis differentiation, and then maleness in the rest of the embryo results from the action of the steroid hormone testosterone and Miillerian-inhibiting substance (MIS, otherwise known as anti-Millerian hormone [AMH]), a member of the transforming growth factor 9 (TGFf3) family of growth factors, secreted by the testis (see Figure 2) .
Sry is thought to encode a transcription factor as it contains an high mobility group (HMG) box type of DNAbinding domain similar to that found in known transcription factors. The DNA-binding domain is highly conserved in different species, but the rest of the SRY protein is not homologous. Whether this means that the HMG domain is the only region of the protein important for function is not known. The HMG domain of SRY binds DNA in a sequence-specific manner and introduces a sharp bend in the double helix. V. Harley (University of Cambridge) discussed evidence showing that mutations in the HMG domain derived from sex-reversed human patients could be separated into those affecting DNA binding and those affecting DNA bending, suggesting that these properties are both important in the function of the SRY protein as a transcriptional regulator. The HMG domain was also found to bind to calmodulin at high affinitites in vitro. The functional significance of this property is unknown, but it suggests that SRY activity may be subject to another level of control.
Srywas previously shown to be expressed by germ cells in adult mouse testis surprisingly as a circular transcript that seems not to be translated (Cape1 et al., 1993) . After an arduous search, the transcript in the developing gonad was found by R. Lovell-Badge (National Institute for Medi- cal Research, London) and colleagues to be a 4.8 kb RNA transcribed from a different promoter than that used in the adult. Sry is turned on specifically in the genital ridge at about 10.5-11 dpc, just before the morphological difference between sexes is observed and is turned off at about 12.5 dpc. Sry is therefore functioning to initiate the pathway of testis differentiation rather than to maintain it. Ft. Lovell-Badge also proposed that it functions as a competence factor, consistent with observations that in some cases Sry expression fails to commit cells to the male pathway. Conversely, ovarian tissuecan transdifferentiate to testicular structures in certain circumstances in the complete absence of Sry.
The Regulatory
Hierarchies Controlling Somatic Sexual Differentiation In the last 15 years, tremendous progress has been made in the understanding of the regulatory hierarchies that transmit the primary sex-determining signal in Drosophila and C. elegans. The power of genetics has led to the identification of many genes essential to somatic sexual differentiation that have been ordered into multistep regulatory hierarchies (see Figure 1) . Interestingly, the ways in which the pathways operate are quite different. In Drosophila the hierarchy functions cell autonomously and involves a positive regulatory cascade of alternative RNA processing decisions, whereas the C. elegans regulatory hierarchy involves a negative cascade that is not completely cell autonomous. The situation in mammals is not as well characterized. Several genes that are thought to be involved in sex determination have been recently identified, but the establishment of a hierarchy is still to come. Drosophila Recent biochemical studies on the Drosophila hierarchy have demonstrated that the pathway contains no gaps; the proteins encoded by the genes that make up the core of the hierarchy (Sxlthrough doublesex [dsx] ) directly regulate the expression of the gene at the next level in the hierarchy (reviewed by McKeown and Madigan, 1992) . This part of the hierarchy involves a cascade of alternative RNA processing decisions, while the top (activation of Sxi) and the bottom of the hierarchy (the downstream function Testis Ovary testosterone of dsx) involve transcriptional regulatory mechanisms. As both RNA splicing and transcription are complex processes involving many factors, a detailed understanding of the mechanisms involved at each step in the hierarchy entails elucidation of how the products of these regulatory genes interact with the basic cellular machinery. Several factors that interact with the hierarchy have been identified (presentation by L. Ryner, Stanford University). For example, the hergene is an essential gene that shows temperature-sensitive maternal and zygotic sex-specific phenotypes (Pultzand Baker, 1995) . Genetic analysis hasshown that her functions both at the top and the bottom of the hierarchy. The sequence of her was reported, revealing the presence of zinc fingers, suggesting a role for her as a transcription factor. Such a role is consistent with the two places in the hierarchy where her functions.
Up to a few years ago, it was thought that all aspects of somatic sexual development were controlled through dsx, as it lies at the bottom of the regulatory hierarchy. However, this notion has changed owing to the discovery made by Taylor (1992) , who found that the development of a male-specific muscle (muscle of Lawrence [MOL]) was not controlled by dsx but was controlled by genes upstream in the hierarchy. This result suggested that there is a previously unrecognized branch to the regulatory hierarchy just downstream of transformer (tra) and tra-2. L. Ryner presented data suggesting that the gene that lies at the top of this newly identified branch is the fruitless (fru) gene. fru contains the same regulatory sequences found in dsx, and mutants of fru show MOL defects, as expected for a gene functioning in this branch (Gailey et al., 1991) . Interestingly, the fru branch controls sexspecific aspects of nervous system function, as MOL development depends on innervation by male-specific motor neurons, and fru mutants exhibit male-specific courtship defects.
Two presentations addressed the specific functions of the fru and dsx branches of the hierarchy. B. Taylor (Oregon State University) discussed the role of the fru branch in controlling cellular and developmental aspects of MOL development. A primary target of control appears to be the recruitment of myoblasts to the developing MOL. K. Burtis (University of California, Davis) discussed several properties of dsx. dsx produces sex-specific polypeptides that function as a transcriptional regulators and control the development of most Sexually dimorphic traits, although yolk protein genes are the only known direct targets (reviewed by Burtis and Wolfner, 1992) . Information on the biochemical properties of dsx molecules was presented, including the identification of a palindromic consensus-binding site and evidence of dimerization between dsx molecules. In addition, an allele-specific interaction between dsx and intersex (ix) (another gene required for female-specific differentiation) was reported, suggesting a possible physical interaction between the proteins of these genes. Last, several promising methods currently being used to look for downstream targets of dsx were described. C. elegans In C. elegans, most of the genes in the pathway have been cloned, but direct interactions among the genes have not yet been demonstrated. It was evident from the meeting that significant progress has been made toward an understanding of each step of the hierarchy. 6. Meyer (University of California, Berkeley) discussed the genes that act at the beginning of the hierarchy that coordinately control both sex determination and dosage compensation. x07-7, the earliest acting gene, functions as a genetic switch: high levels of x0/-7 triggers male development and low levels permit hermaphrodite development (Rhind et al., 1995) . x07-7 directs male development by negatively regulating one or more of the sex determination and dosage compensation (sdc) genes. Molecular data suggest that sdc-2 is the likely target of x0/-7. Evidence for this was presented by B. Meyer, who reported that a sdc-2::lacZ construct is sex-specifically expressed dependent on the activity of x0/-7, suggesting that regulation is transcriptional. The next gene downstream of the sdc genes in the sex determination branch of the hierarchy is her-7. M. Perry (University of Toronto) discussed the analysis of 32 extant her-7 alleles that mapped to all parts of the gene, including several that mapped to the promoter region. Two of these appear to define a promoter site that is involved in the negative regulation of her-7, perhaps by one of the sdc genes. Three other alleles are single base changes in the promoter that cause temperature-sensitive loss of her-7 function. Temperature shift experiments reveal that her-7 is required to specify male sexual fate later in development than was previously thought, from embryogenesis into the Ll larval stage. In addition, her-7 was shown to have a maintenance function in adults asX0 males shifted to the restrictive temperature begin to synthesize hermaphrodite-specific yolk proteins. her-7 encodes a small cysteine-rich secreted protein that may well be a ligand for the product of the next gene downstream, tra-2, which encodes an integral membrane protein. This possible interaction between HER-l and TRA-2 may account for the nonautonomy of sex determination in C. elegans. The genes downstream of fra-2 are the fern genes that, based on their position in the hierarchy between fra-2 and tra-7, may transduce the signal from Pa-2 in the cytoplasmic membrane to tra-7 in the nucleus. J. Hodgkin (Medical Research Council Laboratory for Molecular Biology, Cambridge, England) discussed a possible mechanism for regulation of tra-7. Strikingly, of 30 gain-of-function tra-7 alleles that have been isolated, 29 affect a small stretch of amino acids at the N-terminus, suggesting that this is a site of negative regulation (de Bono et al., 1995) . Because the fern genes negatively regulate Pa-l, their protein products are obvious candidates for interactions with this region, in particular FEM-1, as it contains six ankyrin repeats, a domain found in other proteins involved in protein-protein interactions. Several presentations dealt with the downstream functions of tra-7. The rra-7 gene makes two transcripts, one that encodes a protein with five zinc fingers and the other a truncated version with only the first two of the zinc fingers (Zarkower and Hodgkin, 1992) . Only the larger TRA-1 protein binds DNA in vitro and is thought to be either a negative or positive transcription factor (or both) that regulates a number of downstream targets involved in directing hermaphrodite development. However, it has been proposed that the smaller protein could serve to titrate factors that negatively regulate TRA-1, perhaps through interactions with the N-terminal domain discussed above. Possible targets of TRA-1 are being sought both by looking for genes that have specific roles in the development of sex-specific structures and by using the TRA-1 DNA-binding consensus (Zarkower and Hodgkin, 1993) to screen the C. elegans sequence data base for possible targets. Candidate genes have been identified by both of these means. One possible candidate is the male abnormal gene mab-3 (presented by J. Hodgkin; D. Zarkower, University of Minnesota Medical School). mab-3 functions downstream of tra-7, and mab3 mutants are feminized in more than one tissue type, indicating that mab-3 has a regulatory function. The regulatory nature of mab-3 suggests that it has a relatively upstream position in the sexual developmental program and therefore may be a direct target of TRA-1. S. Emmons (Albert Einstein College of Medicine), who is studying the morphogenesis of the specialized mating structure of the male tail, has identified several genes that are required for ray morphogenesis (rays are peripheral sense organs of the male tail). One of these, /in-32, is a particularly good candidate for a direct target of TRA-1 for two reasons. First, ectopic expression of LIN-32 overcomes regulation by the hierarchy and results in the ectopic production of ray precursors in hermaphrodites, indicating that /in-32 functions downstream of tra-7. Second, a potential TRA-l-binding site is found in the promoter region of /in-32. Interestingly, the ectopic expression result indicates that /in-32 is sufficient to direct epidermal cells into neural fates, which is consistent with /in-32 being a homolog of a Drosophila gene of the achaete-scufe complex (a set of genes involved in Drosophila neurogenesis). Proof of direct interactions between TRA-1 and potential targets awaits biochemical studies. Mammals Little is known about the molecular nature of gonadal differentiation in mammals, although there is substantial knowledge of the cellular processes that occur during early testis and ovary development.
The first cell type to be determined in the developing genital ridge by the action of Sryare the Sertoli cells, and they in turn direct the differentiation of the other cell types in the testis (Burgoyne et al., 1988) . The timing during development of Sry action is critical, as shown in the case of the late-acting Y chromosome from the poschiavinus subspecies of Mus musculus domesticus, which fails to induce testis formation in certain genetic backgrounds.
E. Either (Jackson Laboratories, Bar Harbor, ME) and colleagues have mapped the autosomal loci involved in this effect to chromosomes 2, 4, and 5. The Sty gene is normally necessary and sufficient to determine a testis, but nothing is known about the genes it regulates to produce this effect. Studies by K. McEIreavey (Institut Pasteur, Paris) and colleagues on human XY females and XX males have led to the postulate that SRY acts as a repressor of a negative regulator of testis development. What thesefactorsare is not known. Human sex-reversed patients have been the main source of information on candidate sex determination genes. The establishment of epistatic relationships between these genes and SRY, however, must await their analysis in the mouse.
The gene for a severe dwarfism syndrome, campomelic dysplasia, often associated with XY female sex reversal, has been cloned by A. Schafer (University of Cambridge) and colleagues and by others (Wagner et al., 1994; Wright et al., 1995) . The gene encodes a protein with a DNA-binding domain related to that of SRY and has been named SOX9. The phenotypes of these patients are associated with inactivating mutations within the open reading frame of SOX9 or with translocations at some distance upstream of the gene. These mutations are present in only one allele of the gene, suggesting that sex reversal and campomelic dysplasia in these patients could be due to haploinsufficiency of the SOX9 gene product. Where this gene fits in the sex determination pathway is unknown, and studies in the mouse are underway.
Another case of dosage-sensitive sex reversal in humans is found in XY females that have a duplication in a region of the short arm of the X chromosome. One model for this effect assumes that this region contains a gene, termed DSS for dosage-sensitive sex reversal, which encodes a female specific function. This would normally be negatively regulated by SRY in males, but this repression fails when the gene is present in a double dose and not X inactivated. A gene that encodes a member of the nuclear hormone receptor superfamily has been cloned from this region. This gene has been implicated in the condition known as adrenal hypoplasia congenita (AHC) and has therefore now been named DAX-7 for DSS-AHC critical region on the X chromosome (Zanaria et al., 1994) . A. Swain (National Institute for Medical Research, London) showed that DAX-7 isexpressed in thegenital ridge in mice at 11.5 dpc, consistent with a role in sex determination, but apparently at similar levels in both females and males. If it is to be a candidate for a female-specific function that is negatively regulated in males any repression must be posttranscriptional (see Figure 2 ). Studies in mice on another member of the nuclear hormone receptor superfamily, the steroidogenic factor 1 (SF7) gene, has shown that it is involved in gonad development and possibly in sex determination.
The SF7 gene was first identified as a factor that regulates steroidigenic enzymes in the adrenal cortex and gonads. However, SF7-deficient mice generated by K. Parker (Duke University) and colleagues showed a complete absence of gonads as well as adrenals, implying that the gene has a function in the initial development of these organs before Sry is turned on. Mice lacking the Wilms tumor gene (WT7), a transcription factor involved in kidney development, also show a lack of gonad development (Figure 2 ) but K. Parker reported that this seems to be in a pathway independent of SF7. SF7 has further links to reproduction, as the SF7-deficient mice did not express multiple markers of the gonadotrope lineage and lacked theventromedial hypothalamic nucleus, a region implicated in reproductive behavior.
SF7 has also been implicated in sex determination because of its sexually dimorphic expression in the gonad. Although SF7 transcripts are present in both sexes from early in mouse development, the levels decline in females at about 12 dpc, when morphological differences are occurring (Luo et al., 1994) . Furthermore, studies in vitro have shown that the SF1 protein can bind to the upstream region of the gene encoding Amh, one of the first known markers of Sertoli cells, and activate transcription in cotransfection assays (Shen et al., 1994) . However, because it is expressed earlier and in both sexes, SF7 alone cannot account for the testis-specific activation of Amh expression at 11.5 dpc. Several studies have implied that Sty does not directly activate AMH but acts through an unidentified factor (C. Hagg, Massachusetts General Hospital).
Cell movements between the mesonephros and the gonad are also important in testis formation (Buehr and McLaren, 1993) . B. Cape1 (Duke University) presented data that showed that the migration from the mesonephros to the gonad seems to be greater in an XY versus an XX gonad, highlighting the importance of cell-cell signaling in testis differentiation. Factors that mediate this kind of signaling have not been identified. Differential patterns of expression in the male mouse gonad at the time when Sry is thought to act are found for Amh and for desert hedgehog, a member of a family of proteins that are known to be important in cell signaling. However, mice deficient in either of these genes do not show a phenotype consistent with a role in sex determination (Behringer et al., 1994 ; M. Bitgood, Harvard University). R. Behringer (M. D. Anderson Cancer Center, Houston, TX) presented work on transgenic and mutant mice that showed that Amh is responsible for the regression of the mullerian ducts and suggested that it might be involved in the control of proliferation of steroidogenic cells in the testis. Dosage Compensation Dosage compensation is the process by which the levels of X-linked gene expression is equalized between the sexes. Like other aspects of sex determination, the strategies used to accomplish this are varied. In fact, the model systems fruit flies, worms, and mammals each use a different mechanism. Drosophila In Drosophila, dosage compensation is achieved by elevating the levels of transcripts that are produced from the single X chromosome in males to the level of transcripts produced by both Xs in females (reviewed by Baker et al., 1994) . Four genes that are involved in dosage compensation have been isolated based on the male-specific lethal effects of mutant alleles: m&l, msl-2, msl-3, and m/e, collectively called the msls. All four msl genes have been cloned, with the molecular characterization of msl-2 being reported at this Keystone meeting (presentation by M. Kuroda, Baylor College of Medicine; also reported by 6. Baker, Stanford University, and J. Lucchesi, Emory University). Through the use of antibodies directed against each of the msl proteins, it has been shown that each of the msls is localized to hundreds of specific sites along the length of the X chromosome in males, but not in females, suggesting that the msls are direct mediators of dosage compensation and that they may work together to regulate the same set of X-linked genes. In addition, an isoform of histone H4 acetylated at Lys-16 (H4Acl6) also associates mainly with the male X chromosome. The X chromosome binding of each of the msls and H4Ac16 depends on the wild-type function of all the msls, suggesting that these gene products may associate with one another in a heteromerit complex. Biochemical evidence for such an interaction was presented by M. Kuroda, who reported coimmunoprecipitation of msl-1 and msl-2 from male larval extracts.
How is dosage compensation controlled in Drosophila? Several lines of evidence indicate that Sxl negatively regulates dosage compensation by preventing hypertranscription of the females X chromosomes.
In addition, genetic data are consistent with Sxlfunctioning as an on/off switch to control dosage compensation as it does to control somatic sexual differentiation (Cline, 1984) ; however, conflicting data on this point are present in the literature (reviewed by Lucchesi and Manning, 1987) . Recently, using specific polyclonal antibodies, the association of the msls and H4Ac16 with the X chromosome has been examined in flies that are mosaic for Sxl expression. This analysis has shown that, at the cellular level, there is a perfect inverse correlation of Sxl expression and msl association with the X chromosome, indicative of Sxl functioning as an on/off switch to control dosage compensation (reviewed by Baker et al., 1994) . The same type of analysis has been used to examine whether 2X:3A intersexes are intermediate in their expression of X-linked genes owing to mosaicism (some cells "on" and some cells "off") or owing to intermediate levels of hypertranscription in each cell. At the meeting B. Baker reported that, indeed, 2X:3A intersexes are mosaics for msl binding, providing direct evidence that Sxl works as an on/off switch to control dosage compensation.
A. Hilfiker (Emory University) discussed the role of Sxl and virilizer (vir), another gene known to be involved in sex determination, in dosage compensation. He found that the activity of vir is required for femalespecific splicing of Sxl transcripts and that certain combinations of virand Sxlalleles lead to X chromosome association of msls in larval tissues of XX females, but that these same animals can develop into normal, viable female adults.
Sxl could negatively regulate dosage compensation by "turning off" the expression of one of the msls. M. Kuroda presented data showing that msl-2 protein appears to be male specific (the other msls are detected in both sexes) and that ectopic expression of msl-2 in females leads to accumulation of the other msls on the females X chromosomes and decreased viability, both signs of upsets in dosage compensation. These results indicate that msl-2 behaves as a dosage compensation switch gene and is good candidate for the target of Sxl regulation. Because Sxl functions as an RNA-binding protein that regulates RNA splicing decisions to control somatic sexual differentiation, it is reasonable to expect that control of dosage compensation should occur through a similar mechanism. J. Lucchesi reported that a sex-specific alternative RNA splicing event occurs in the S'untranslated region (SUTR) of msl-2 transcripts: an intron that is removed in males and retained in females has consensus Sxl-binding sites near the two splice junctions, suggesting that splicing of the intron is dependent on the activity of Sxl (Zhou et al., 1995) . In addition, M. Kuroda presented evidence that sequences in the msl-2 B'UTR also contribute to the sexspecific expression of ms/-2, suggesting that Sxl may do more than just control RNA splicing. C. elegans In C. elegans, dosage compensation is accomplished by reducing the expression of X-linked genes in XX hermaphrodites. Five genes, dpy-21, dpy-26, dpy-27, dpy-28, and dpy-30, have been identified that function in the dosage compensation process. Mutations in these genes kill or enfeebleXX hermaphrodites.
Noneof these genes, except dpy-30, is required in X0 animals, and all, except for dpy-27, are required maternally in XX embryos. As in Drosophila, dosage compensation and sex determination are coordinately controlled by the sex determination hierarchy. In XX animals the sdc genes control both processes by activating dosage compensation and repressing the malespecific sex determination genes. Until very recently, relatively little was known about how the sdc and dpy genes control dosage compensation. The recent molecular cloning and characterization of dpy-27 has led to significant insights into this problem.
DPY-27 is a member of the expanding SMC family of proteins involved in chromosome condensation (Chuang et al., 1994) . Antibodies against DPY-27 show a diffuse nuclear staining in both XX and X0 oocytes and early embryos. However, the staining becomes localized to the X chromosome in XX embryos at the 30-cell stage (and in X0 embryos that activate the XX mode of dosage compensation). These resultssuggest that dpy-27maydirectly regulate dosage compensation by influencing higher order chromosome structure of the X chromosome that could result in a reduction of X-linked gene expression (Chuang et al., 1994) . Data regarding how regulation of dosage compensation is achieved were presented by P.-T. Chuang (University of California, Berkeley). By looking at DPY-27 staining in various mutant backgrounds, it was shown that X chromosome localization of DPY-27 requires the wildtype activity of sdc-2, sdc3, and dpy-30. Because sdc-2 appears to be required zygotically and is expressed specifically in hermaphrodites, sdc-2 may be the sex-specific factor required for DPY-27 X chromosome localization. In addition, dpy-26 and dpy-28 may be required for the production or stability of DPY-27 as staining is severely reduced in these mutant backgrounds.
Interestingly, SDC3 may also be localized to the X chromosome. Based on this and the fact that SDC-3 contains a pair of zinc fingers, it was suggested that SDC-3 might be the factor that confers X chromosome specificity to DPY-27. It is clear from these types of analyses that a mechanistic model for the dosage compensation process in C. elegans will be forthcoming in the near future. Mammals Dosage compensation is achieved by inactivating one of the two X chromosomes in the female. The process of X inactivation is controlled by a &acting locus termed the X inactivation center (XIC). The Xist gene maps to the XIC region on the mouse and human X chromosome and is expressed only from the inactive X, making it a strong candidate for XIC itself. The gene encodes a 15 kb transcript in mouse that shows several regions of high sequence similarity with the human transcript, but it does not contain any significant or conserved open reading frame (reviewed by Rastan, 1994) . The Xist RNA could be the functional unit in the process of X inactivation, but it is formally possible that it is merely the act of transcribing the gene that is important. In support of the former, H. Willard (Case Western Reserve University) presented data showing that Xist RNA interacts with the inactive X, apparently along most of its length, in interphase nuclei, but intriguingly it is dispersed during mitosis. It is not known whether it reassociates after mitosis or whether only nascent transcripts are able to bind. The chromatin components with which it interacts are presently unknown.
Expression of the Xist gene just precedes the onset of X inactivation in mouse development, and it is thought to be involved in the initiation of inactivation. To study the role of Xist in this process, N. Brockdorff (Medical Research Council Clinical Science Centre, Cambridge) and colleagues used gene targeting by homologous recombination to create XX embryonic stem (ES) cells with a 7 kb deletion at the beginning of the Xist transcription unit in one X chromosome. XX ES cells have two active X chromosomes; upon differentiation, random X inactivation occurs. The targeted cells showed cytological X inactivation after differentiation, and Xist was expressed from the normal X suggesting that the deletion does not affect the initial signal that "counts" the number of X chromosomes. The targeted ES cells contained X chromosomes from widely different mouse strains, such that polymorphisms could be used to distinguish transcripts from several genes along the deleted and normal X and therefore assess the state of X inactivation. The results suggested that the targeted cells differentiate into two populations, those that select the normal X for inactivation undergoing normal X inactivation and those that select the targeted X failing to inactivate. The data strongly suggest that Xi.9 transcripts are required in cis to inactivate genes along the X, but not for the counting process.
Sex Determination in the Germline The generation of sperm and eggs is perhaps the most essential aspect of sex-specific differentiation for sexual reproduction, yet studies of germline sex determination have lagged behind studies of other aspects of sexual differentiation. The primary reason for this seems to be that sex-transformed germ cells are not as easily detected as sex-transformed somatic structures. Nonetheless, significant progress has been made in recent years toward a molecular understanding of germline sex determination. Drosophila In Drosophila, the sex of germ cells is determined by both autonomous and inductive signals (reviewed by Steinmann-Zwicky, 1992). Evidence from experiments in which XX and XY germ cells are transplanted into hosts of the opposite sex have shown that the sex of XX germ cells is determined by an inductive signal from the gonadal soma. However, XY germ cells are unresponsive to this signal: they are male irrespective of their environment. The genes that control somatic sex determination do not determine the sex of the germline, with the exception of Sxl, whose product is required in germ cells for oogenesis. Furthermore, the factors that make up the X:A ratio and function to initiate Sxl expression in the soma (such as sis a, sis b, and da) do not have this same function in the germline. In addition, Sxl seems to be required relatively late for oogenesis, at metamorphosis (Steinmann-Zwicky, 1994 ). This leaves several open questions. What is the role of Sxl in the germline? How is Sxlactivated in ovaries? What are the factors that control sex determination in the germline? And when do they act?
Three presentations at the meeting dealt with answering these questions. First, T. Cline showed that in the germline Sxl does not operate as a genetic switch like it does in the soma: Sxl activity in the germline is not sufficient to direct XY germ cells into the oogenic pathway, even in the context of a feminized soma. Second, he showed that Sxl autoregulation, the process by which the Sxl protein directs the splicing of its own transcript into a protein expressing form in the soma, also occurs in the germline. However, Sxl germline autoregulation does not depend strictly on somatic inputs nor the germline X:A ratio, suggesting that the control point for Sxl function in the germline is not through the autoregulation process itself but instead lies at an initiation step. Interestingly, Sxl expression in the germline may be, in part, directly controlled by the dose of X-linked factors that are involved in regulating Sxl RNA splicing.
Second, B. Oliver (Centre National de la Recherche Scientifique, Marseille) discussed the role of ovo in germline sex determination.
ovo functions upstream of Sxl in a germline regulatory hierarchy and is specifically required for XX germ cell viability. However, the lethality of XX germ cells observed in ovo mutants is partially suppressed by mutations in the dosage compensation gene m/e, sug-gesting a possible role for ovo in germ cell dosage compensation (Oliver et al., 1993) . Interestingly, ovo appears to be sex-specifically regulated as ovo::/acZ constructs are expressed at high levels in females and low levels in males. Third, M. Steinmann-Zwicky (University of Zurich) discussed the timing of sex determination in the germline and suggested that while Sxl is a target of an inductive signal from the soma, it may not be the initial determinant of sex in the germline. Germ cells first display sexual dimorphism during embryogenesis, when Sxl is not yet required for germ cell sex determination. Therefore, to study the initial aspects of germline sex determination, M. Steinmann-Zwicky is studying enhancer trap lines that are expressed in the gonads of young animals. One line is particularly useful as it is expressed only in stem cells of the male germline and can be detected during embryogenesis. Studies with this marker suggest that both inductive and autonomous signals operate already in embryogenesis and that the sex of germ cells is reversible until fairly late in development. C. elegans In contrast with Drosophila, sex determination in the germline of C. elegans uses all the same genes that are used for sex determination in the soma, with acoupleof differences (reviewed by Parkhurst and Meneely, 1994) . These include, first, that the fern genes may act at the bottom of the germline pathway to bring about spermatogenesis directly, instead of through the down-regulation of fra-7. Second, the function of tra-7 in the germline is more complex than in the soma and appears to have a role in gametogenesis in both sexes. In addition, several genes have been identified that function specifically in germline sex determination (the mog and fog genes, named for masculinizing and feminizing of the germline). However, the specific functions of these genes are presently unknown.
Hermaphrodite development can be viewed as essentially female development with a short period of male germline development to produce sperm before oogenesis ensues. To achieve spermatogenesis in hermaphrodites, tra-2 is transiently inactivated in the gonad. One way this is thought to occur is by translational repression of tra-2. tra-2 contains two direct repeats in its 3'lJTR (termed the DREs, for direct repeat elements) known to be necessary for translational repression (Goodwin et al., 1993) . A possible candidate for the factor that binds the DREs and represses translation was discussed by E. B. Goodwin (Northwestern University). The gene, called laf-7 (for lethal and feminizing), was isolated as a dominant suppressor of the mogphenotype and is homozygous lethal. Two lines of evidence were presented that suggest that laf-7 is responsible for modulation of tra-2 translation: laf-7 appears to act upstream of Pa-2 in a genetic pathway, and ectopic expression of a IacZ reporter construct containing the DREs is observed in a laf-7/+ background, indicating that laf-7 is required for translation repression through the DREs. Interestingly, epistasis tests of laf-7 with tra-7 and tra-2 suggests that tra-7 and tra-2 may act in parallel instead of in the generally accepted linear pathway and that Pa-7 may not be the sole terminal regulator in the sex determination pathway. However, further experiments are required to test these suggestions.
T. Schedl (Washington University) discussed the function of g/d-l (defective in germline development), a tumor suppressor gene required for oocyte development (Francis et al., 1995) . Germ cells of g/d-l-null mutant hermaphrodites enter meiosis normally but then return to mitosis at the pachytene stage and form germline tumors where oocytes normally form. When the pathway is set in the male mode, these oocytes develop into sperm, indicating that g/d-l function is not essential for spermatogenesis. However, g/d-l may function to promote spermatogenesis in hermaphrodites and may have a nonessential role in regulating germ cell proliferation in both sexes. Molecular analysis of g/d-l was reported at the meeting and reveals that g/d-l expression is germline specific and the product is apparently cytoplasmic. It contains a region with similarity to mammalian Sam68 (Src associated in mitosis protein ~68) that includesan RNA-binding KH domain, suggesting that the way that g/d-l functions is by effecting translation or transcript stability of target mRNAs. Mammals The sexual phenotype of germ cells in mammals is not dependent on the genotype of the germ cells but on the sex of the surrounding gonadal tissue. In the mouse, at about 10-l 1 dpc germ cells migrate into the genital ridge, where they proliferate for 2-3 days before they first begin to show sex differences. In the ovary, germ cells enter meiosis and then arrest at the prophase of the first meiotic division. In the testis the germ cells enter mitotic arrest at about 13 days. The germ cells then resume proliferation after birth, not entering meiosis until much later. P. Burgoyne (National Institute for Medical Research, London) discussed what he called meioticquality control, a process that operates when chromosomes remain unpaired during meoisis. By looking at mice that were male because they have part of the Y chromosome that includes Sry attached to the X, but lack the pairing region, it was possible to show that the process operates via apoptosis.
Mouse germ cells that have migrated into other organs such as adrenals (in either a female or male embryo) enter meiotic arrest whether they are XX or XY. This suggests that the testis is producing a mitotic inhibitor substance. The molecular nature of this factor is not known. A. McLaren (University of Cambridge) described reaggregation studies to test whether there may also be a meiosisinducing substance; in these studies, germ cells from the gonads were taken at different stages of development and cultured with cells from various sources, including lung. The germ cells derived from female and young male (10.5-11.5 dpc) gonads entered meiosis in the lung cultures at about the same time they would do so in the ovary, arguing that if a meiotic inducer is necessary for germ cell development, it is not a gonad/adrenal-specific factor. In these cultures, germ cells derived from older testis (12.5 dpc or more) entered mitotic arrest, indicating that germ cells in the testis become committed to mitotic arrest in the testis to a period between 11.5 and 12.5 dpc. These experiments also suggested that germ cells have a cell autonomous timing system to enter meiosis that is only overridden if they are located in the testis.
Not much is known about factors that control sexual differences in the germ cells, although growth factors that affect germ cell survival, proliferation, and migration have been identified. The steel (9) gene product, a mast cell growth factor, and its receptor (encoded by the W locus) are known to be needed for proper migration and proliferation. P. Donovan (Applied Biosystems Bbsic Research Program, Frederick, Maryland) described two alleles of the SI locus in mice. In SI 77H, which is a mutation in the cytoplasmic tail of this transmembrane growth factor, the males are sterile owing to degeneration of spermatogonia, but the females are fertile. In SI panda, where regulation of the gene is affected, the males are fertile and the females are sterile owing to a failure in the maintenance of the follicle cells that surround the germ cells.
Sex Determination
in Other Systems A session was dedicated to sex determination in organisms other than the well-studied Drosophila, C. elegans, and mice. These studies reinforce how varied the mechanisms can be and how extrapolation between systems is a dangerous business. House Fly A. Dubendorfer (University of Zurich) reviewed the situation for the house fly, Musca domestica, where sex is determined by the presence of a dominant maledetermining factor M and is independent of dosage compensation. M is usually found on the Y chromosome but in some strains can be autosomal. It is thought that M acts early and transiently in development to repress a gene, F, that is continuously required for female development. Transplantation experiments showed that germ cell sex determination in these animals is dependent on the surrounding soma and not on its genotype, like the situation in the mouse. A homolog to Drosophila Sxl has been observed in Musca, but it is expressed in both females and males, suggesting that it might not have a fundamental role in sex determination. Marsupials Marsupial testis formation is dependent on the presence of the Y chromosome like eutherian mammals. M. Renfree (University of Melbourne) reported on the characterization of the homolog of Sry in these animals. The expression was found not to be restricted to gonadal tissues and remains "on" for much longer than seen in the mouse. However, this is also to true for humans and may not reflect a marsupial-eutherian dichotomy. An intriguing difference in sex determination observed between marsupials and eutherian mammals is that several structures, such as the scrotum in males and the pouch and mammary primordia in females, develop before gonadal differentiation is complete. Interestingly, these dimorphic characteristics are under the direct control of the X chromosome and independent of the Y. The identities of the X-linked genes involved in this process are not known. Spotted Hyena P. Licht (University of California, Berkeley) reviewed the case of the female spotted hyena that displays many external characteristics that are identified with maleness in mammals. They have no Vagina, as the vaginal labia have fused to form a pseudoscrotum, and they have a structure that looks like a penis through which they urinate, copulate, and give,birth. The behavior of these females is highly aggressive and dominant right !rom birth. In mammals, male secondary sexual characteristics are regulated by testosterone produced by the testis. Female hyenas have lower levels of testosterone than the normal levels seen in males but have higher androstenedione, an intermediate in the testosterone production pathway. When females are pregnant, this androstenedione is converted to testosterone by the placenta and transferred to the fetus. The. hyena placenta does not have the protective mechanisms seen, for example, in humans that prevent testosterone reaching and masculininzing the fetus. Hyena fetuses were treated with an anti-androgen drug, but surprisingly thefemalesdid not lose their masculine traits, although the males were affected as they showed phalluses resembling those seen on females. It is clear that hyenas have the last laugh. Fern In the fern Ceratopteris richardii, the determinant of sex is the pheromone antheridiogen (Ace), which acts by promoting male development of the haploid spore. In the absence of Ace, spores develop as hermaphrodites. These produce and secrete Ace that will determine the sex of the surrounding slower germinating spores as males. Abscisic acid blocks the Ace response in these plants. J. Banks (Purdue University) described various classes of mutations that affect sex determination and response to Ace and abscisic acid. The epistatic relationship between these mutations was elegantly presented showing the beginnings of a hierarchy in the establishment of sexual differences in Ceratopteris. The molecular nature of these factors is not yet known.
Evolution of Sex Chromosomes B. Charlesworth (University of Chicago) discussed several mechanisms of how sex chromosomes could have evolved. The switch from the ancient cosexual state to dioecy involves the occurrence of two mutation steps: a male sterility mutation converting cosexuals into females and a female sterility mutation converting cosexuals into males. Assuming an initial recessive male sterility mutation, a subsequent dominant female sterility mutation will occur that must be located at a closely linked locus to avoid recombination to give individuals with male and female sterility. This series of events would create the proto-X chromosome that could carry the female fertility and male sterility genes and the proto-\/ chromosome with the female sterility and male fertility genes. Selection for differences between the sexes would follow and determine the reduced genetic exchange over a wide region between the proto-X and proto-\/. A consequence of the lack of recombination will be the accumulation of deleterious mu-tations, transposable elements, and tandem DNA repeats on the proto-Y leading to a chromosome that is different to the X and is genetically inert, except for the sex-specific function. The accumulation of deleterious mutations on the proto-\/ could be due to a stochastic process (Mullet+ ratchet) or could spread by association with favorable Y-linked mutant alleles (hitchhiking model). In either case, the activity of the X in the regions not related to sexual functions is increased relative to the Y in the heterogametic sex and a system for dosage compensation must then evolve.
J. Graves (La Trobe University) discussed how studying sex chromosomes in marsupials and monotremes has provided valuable information on mechanisms of evolution. There is high homology between the X and Y in these animals, consistent with the proposal that the sex chromosomes evolved from a homologous pair of autosomes. In marsupials, only the paternally derived X is inactivated, a possible intermediate in the process that gave rise to the random X inactivation system seen in eutherian mammals. The long arm and proximal short arm of the X chromosome show conserved positions of loci between marsupials and humans, implying that this region was present in the ancestral X. In contrast, loci on the short arm of the human X, which includes the pseudoautosomal or pairing region where recombination between the X and Y occurs, map to two clusters of autosomal loci in marsupials and monotremes. This suggests that the short arm of the X was created by addition of a piece of an autosome to the ancestral X. A homolog to SRY is found on the marsupial Y but not as yet in monotremes, implying that this gene has a recent evolutionary history. The wider expression pattern seen for the marsupial SRY gene compared with that in eutherian mammals led J. Graves to suggest that it could reflect the expression of the ancestral gene from which SRY evolved. This is thought to be the gene SOX3, which, of the many SOX genes being found, is closest to SRY in terms of sequence within its HMG box DNA-binding domain and is also X linked in both marsupial and eutherian mammals.
Closing Remarks This is a time of rapid progress in the field of sex determination. Because of the diversity of mechanisms used to control sex determination, lessons learned from the study of various model organisms should continue to surprize and remind us of the importance of sex. We congratulate B. Baker, R. Lovell-Badge, and B. Meyer for organizing such a stimulating meeting. A special thanks goes to B. Baker and Ft. Lovell-Badge for their help and support during the writing of this review. We also thank I. Marin, B. Meyer, and all the other presenters who commented on the review.
